SYNTHIA FRANK: Open Payments
NPI 1902428386 · LEITCHFIELD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 67 payments from 20 companies in 2025. Trend: 2023 $618 · 2024 $945 · 2025 $978
Food & beverage: $967Education: $11
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 13 | $199 |
| ABBVIE INC. | 18 | $139 |
| Axsome Therapeutics, Inc. | 6 | $97 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $61 |
| Vanda Pharmaceuticals Inc. | 3 | $60 |
| PFIZER INC. | 2 | $41 |
| Novo Nordisk Inc | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
Products named: Korlym, Auvelity, Kerendia, CAPLYTA, VRAYLAR, FANAPT, UBRELVY, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
